Changes in low-value services in year 1 of the medicare pioneer accountable care organization program

JAMA Internal Medicine

Volumn 175, Issue 11, 2015, Pages 1815-1825

  Schwartz, Aaron L ^a   Chernew, Michael E ^b   Landon, Bruce E ^c   Michael McWilliams, J ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCOUNTABLE CARE ORGANIZATION; AGED; ARTICLE; CANCER SCREENING; CARDIOVASCULAR PROCEDURE; CARDIOVASCULAR SYSTEM EXAMINATION; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; GEOGRAPHY; HEALTH CARE COST; HEALTH CARE PERSONNEL; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HEALTH SERVICE; HUMAN; IMAGING; MAJOR CLINICAL STUDY; MALE; MEDICAL FEE; MEDICARE; PATIENT CARE; PATIENT PREFERENCE; PRIORITY JOURNAL; COST CONTROL; ECONOMICS; HEALTH CARE MANAGEMENT; HEALTH CARE POLICY; OUTCOME ASSESSMENT; PROCEDURES; STATISTICS AND NUMERICAL DATA; UNITED STATES;

ACCOUNTABLE CARE ORGANIZATIONS; AGED; ANNUAL REPORTS AS TOPIC; COST SAVINGS; FEE-FOR-SERVICE PLANS; FEMALE; HEALTH EXPENDITURES; HUMANS; MALE; MEDICARE; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT PROTECTION AND AFFORDABLE CARE ACT; UNITED STATES;

EID: 84946143486     PISSN: 21686106     EISSN: 21686114     Source Type: Journal    
DOI: 10.1001/jamainternmed.2015.4525     Document Type: Article

References (74)

1. Berwick DM, Hackbarth AD. Eliminating waste in US health care. JAMA. 2012;307(14):1513-1516.
2. Burwell SM. Setting value-based payment goals-HHS efforts to improve U.S. health care. N Engl J Med. 2015;372(10):897-899.
3. Coulam RF, Gaumer GL. Medicares prospective payment system: a critical appraisal. Health Care Financ Rev Annu Suppl. 1991:45-77.
4. McGuire TG, Newhouse JP, Sinaiko AD. An economic history of Medicare part C. Milbank Q. 2011;89(2):289-332.
5. Song Z, Chokshi DA. The role of private payers in payment reform. JAMA. 2015;313(1):25-26.
6. Choudhry NK, Rosenthal MB, Milstein A. Assessing the evidence for value-based insurance design. Health Aff (Millwood). 2010;29(11):1988-1994.
7. Cassel CK, Guest JA. Choosing Wisely: helping physicians and patients make smart decisions about their care. JAMA. 2012;307(17):1801-1802.
8. Schwartz AL, Landon BE, Elshaug AG, Chernew ME, McWilliams JM. Measuring low-value care in Medicare. JAMA Intern Med. 2014;174(7):1067-1076.
9. Colla CH, Morden NE, Sequist TD, SchperoWL, Rosenthal MB. Choosing Wisely: prevalence and correlates of low-value health care services in the United States. J Gen Intern Med. 2015;30(2):221-228.
10. Elshaug AG, McWilliams JM, Landon BE. The value of low-value lists. JAMA. 2013;309(8):775-776.
11. Colla CH. Swimming against the current?what might work to reduce low-value care? N Engl J Med. 2014;371(14):1280-1283.
12. McWilliams JM, Landon BE, Chernew ME, Zaslavsky AM. Changes in patients experiences in Medicare accountable care organizations. N Engl J Med. 2014;371(18):1715-1724.
13. Song Z, Rose S, Safran DG, Landon BE, Day MP, Chernew ME. Changes in health care spending and quality 4 years into global payment. N Engl J Med. 2014;371(18):1704-1714.
14. Song Z, Safran DG, Landon BE, et al. Health care spending and quality in year 1 of the alternative quality contract. N Engl J Med. 2011;365(10):909-918.
15. McWilliams JM, Landon BE, Chernew ME. Changes in health care spending and quality for Medicare beneficiaries associatedwith a commercial ACOcontract. JAMA. 2013;310(8):829-836.
16. McWilliams JM, Chernew ME, Landon BE, Schwartz AL. Performance differences in year 1 of Pioneer accountable care organizations. N Engl J Med. 2015;372(20):1927-1936.
17. Centers for Medicare &Medicaid Services (CMS), HHS. Medicare program; Medicare Shared Savings Program: accountable care organizations. Final rule. Fed Regist. 2011;76(212):67802-67990.
18. Choosing Wisely. Lists of five things physicians and patients should question. http://www .choosingwisely.org/doctor-patient-lists/. Accessed February 16, 2015.
19. US Preventive Services Task Force. Published recommendations. http://uspreventiveservicestaskforce.org/BrowseRec/Index/browse-recommendations. Accessed February 16, 2015.
20. Canadian Agency for Drugs and Technologies in Health. Health technology assessments. https://www.cadth.ca/resources/hta-database-canadian-search-interface. Accessed February 16, 2015.
21. Elshaug AG, Watt AM, Mundy L, Willis CD. Over 150 potentially low-value health care practices: an Australian study. Med J Aust. 2012;197(10):556-560.
22. American Medical Association. CodeManager Online. https://ocm.ama-Assn.org/OCM/mainMenu .do. Accessed November 1, 2014.
23. Centers for Medicare and Medicaid Services. ICD-9-CM Diagnosis and Procedure Codes: abbreviated and full code titles. https://www.cms.gov/Medicare/Coding/ICD9ProviderDiagnosticCodes/codes.html. AccessedNovember 1, 2014.
24. Chronic Conditions DataWarehouse. http://www.ccwdata.org/. Accessed February 16, 2015.
25. Holley JL. Screening, diagnosis, and treatment of cancer in long-term dialysis patients. Clin J Am Soc Nephrol. 2007;2(3):604-610.
26. Vesco K, Whitlock E, Eder M, et al. Screening for Cervical Cancer: A Systematic Evidence Reviewfor the US Preventive Services Task Force. Rockville, MD: Agency for Healthcare Research and Quality; 2011.
27. Whitlock EP, Lin JS, Liles E, Beil TL, Fu R. Screening for colorectal cancer: a targeted, updated systematic review for the US Preventive Services Task Force. Ann Intern Med. 2008;149(9):638-658.
28. Lin K, Lipsitz R, Miller T, Janakiraman S; U.S. Preventive Services Task Force. Benefits and harms of prostate-specific antigen screening for prostate cancer: an evidence update for the U.S. Preventive Services Task Force. Ann Intern Med. 2008;149 (3):192-199.
29. Bell KJL, Hayen A, Macaskill P, et al. Value of routine monitoring of bone mineral density after starting bisphosphonate treatment: secondary analysis of trial data. BMJ. 2009;338:b2266.
30. Hillier TA, Stone KL, Bauer DC, et al. Evaluating the value of repeat bone mineral density measurement and prediction of fractures in older women: the Study of Osteoporotic Fractures. Arch Intern Med. 2007;167(2):155-160.
31. Mart-Carvajal AJ, Sol I, Lathyris D, Karakitsiou D-E, Simancas-Racines D. Homocysteine-lowering interventions for preventing cardiovascular events. Cochrane Database Syst Rev. 2013;1:CD006612. doi:10.1002/14651858.CD006612.pub3.
32. Baglin T, Gray E, GreavesM, et al; British Committee for Standards in Haematology. Clinical guidelines for testing for heritable thrombophilia. Br J Haematol. 2010;149(2):209-220.
33. Levin A, Bakris GL, MolitchM, et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int. 2007;71(1):31-38.
34. Palmer SC, McGregor DO, Craig JC, Elder G, Macaskill P, Strippoli GF. Vitamin D compounds for people with chronic kidney disease not requiring dialysis. Cochrane Database Syst Rev. 2009;(4): CD008175. doi:10.1002/14651858.CD008175.
35. Garber JR, Cobin RH, Gharib H, et al; American Association of Clinical Endocrinologists and American Thyroid Association Taskforce on Hypothyroidism in Adults. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract. 2012;18(6):988-1028.
36. HolickMF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266-281.
37. Mohammed T, Kirsch J, Amorosa J, et al. ACR Appropriateness Criteria Routine Admission and Preoperative Chest Radiography. Reston, VA: American College of Radiology; 2011.
38. Joo HS, Wong J, Naik VN, Savoldelli GL. The value of screening preoperative chest x-rays: a systematic review. Can J Anaesth. 2005;52(6): 568-574.
39. Douglas PS, GarciaMJ, Haines DE, et al; American College of Cardiology Foundation Appropriate Use Criteria Task Force; American Society of Echocardiography; American Heart Association; American Society of Nuclear Cardiology; Heart Failure Society of America; Heart Rhythm Society; Society for Cardiovascular Angiography and Interventions; Society of Critical Care Medicine; Society of Cardiovascular Computed Tomography; Society for Cardiovascular Magnetic Resonance. ACCF/ASE/AHA/ASNC/HFSA/HRS/SCAI/SCCM/SCCT/SCMR 2011 appropriate use criteria for echocardiography. A report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Society of Echocardiography, American Heart Association, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Critical Care Medicine, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance endorsed by the American College of Chest Physicians. J AmColl Cardiol. 2011; 57(9):1126-1166.
40. Qaseem A, Snow V, Fitterman N, et al; Clinical Efficacy Assessment Subcommittee of the American College of Physicians. Risk assessment for and strategies to reduce perioperative pulmonary complications for patients undergoing noncardiothoracic surgery: a guideline from the American College of Physicians. Ann Intern Med. 2006;144(8):575-580.
41. Fleisher LA, Beckman JA, Brown KA, et al; American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery); American Society of Echocardiography; American Society of Nuclear Cardiology; Heart Rhythm Society; Society of Cardiovascular Anesthesiologists; Society for Cardiovascular Angiography and Interventions; Society for Vascular Medicine and Biology; Society for Vascular Surgery. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation. 2007;116(17):e418-e499. doi: 10.1161/CIRCULATIONAHA.107.185699.
42. Cornelius RS, Martin J, Wippold FJ, et al; American College of Radiology. ACR appropriateness criteria sinonasal disease. J AmColl Radiol. 2013;10(4):241-246.
43. Moya A, Sutton R, Ammirati F, et al; Task Force for the Diagnosis and Management of Syncope; European Society of Cardiology (ESC); European Heart Rhythm Association (EHRA); Heart Failure Association (HFA); Heart Rhythm Society (HRS). Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J. 2009;30(21): 2631-2671.
44. Jordan J, Wippold FI, Cornelius R, et al. ACR Appropriateness Criteria: Headache. Reston, VA: American College of Radiology; 2009.
45. Gronseth GS, Greenberg MK. The utility of the electroencephalogram in the evaluation of patients presenting with headache: a review of the literature. Neurology. 1995;45(7):1263-1267.
46. Chou R, Fu R, Carrino JA, Deyo RA. Imaging strategies for low-back pain: systematic review and meta-Analysis. Lancet. 2009;373(9662):463-472.
47. Wolff T, Guirguis-Blake J, Miller T, GillespieM, Harris R. Screening for carotid artery stenosis: an update of the evidence for the US Preventive Services Task Force. Ann Intern Med. 2007;147(12): 860-870.
48. Buchbinder R. Plantar fasciitis. N Engl J Med. 2004;350(21):2159-2166.
49. Hendel RC, Berman DS, Di Carli MF, et al; American College of Cardiology Foundation Appropriate Use Criteria Task Force; American Society of Nuclear Cardiology; American College of Radiology; American Heart Association; American Society of Echocardiography; Society of Cardiovascular Computed Tomography; Society for CardiovascularMagnetic Resonance; Society of Nuclear Medicine. ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 appropriate use criteria for cardiac radionuclide imaging: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the American Society of Nuclear Cardiology, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the Society of Cardiovascular Computed Tomography, the Society for CardiovascularMagnetic Resonance, and the Society of Nuclear Medicine. Circulation. 2009;119(22): e561-e587. doi:10.1161/CIRCULATIONAHA.109.192519.
50. Boden WE, ORourke RA, Teo KK, et al; COURAGE Trial Research Group. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356(15):1503-1516.
51. Lin GA, Dudley RA, Redberg RF. Cardiologists use of percutaneous coronary interventions for stable coronary artery disease. Arch Intern Med. 2007;167(15):1604-1609.
52. Wheatley K, Ives N, Gray R, et al; ASTRAL Investigators. Revascularization versus medical therapy for renal-Artery stenosis. N Engl J Med. 2009;361(20):1953-1962.
53. Cooper CJ, Murphy TP, Cutlip DE, et al; CORAL Investigators. Stenting and medical therapy for atherosclerotic renal-Artery stenosis. N Engl J Med. 2014;370(1):13-22.
54. Goldstein LB, Bushnell CD, Adams RJ, et al; American Heart Association Stroke Council; Council on Cardiovascular Nursing; Council on Epidemiology and Prevention; Council for High Blood Pressure Research; Council on Peripheral Vascular Disease; Interdisciplinary Council on Quality of Care and Outcomes Research. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42(2):517-584.
55. PREPIC Study Group. Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque dEmbolie Pulmonaire par Interruption Cave) randomized study. Circulation. 2005;112(3):416-422.
56. Sarosiek S, Crowther M, Sloan JM. Indications, complications, and management of inferior vena cava filters: the experience in 952 patients at an academic hospital with a level I trauma center. JAMA Intern Med. 2013;173(7):513-517.
57. Rajaram SS, Desai NK, Kalra A, et al. Pulmonary artery catheters for adult patients in intensive care. Cochrane Database Syst Rev. 2013;2:CD003408. doi:10.1002/14651858.CD003408.pub3.
58. Kallmes DF, Comstock BA, Heagerty PJ, et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures. N Engl J Med. 2009; 361(6):569-579.
59. Buchbinder R, Osborne RH, Ebeling PR, et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures. N Engl J Med. 2009;361(6):557-568.
60. Boonen S, Van Meirhaeghe J, Bastian L, et al. Balloon kyphoplasty for the treatment of acute vertebral compression fractures: 2-year results from a randomized trial. J Bone Miner Res. 2011;26 (7):1627-1637.
61. LaupattarakasemW, Laopaiboon M, Laupattarakasem P, Sumananont C. Arthroscopic debridement for knee osteoarthritis. Cochrane Database Syst Rev. 2008;(1):CD005118. doi:10 .1002/14651858.CD005118.pub2
62. Pinto RZ, Maher CG, FerreiraML, et al. Epidural corticosteroid injections in the management of sciatica: a systematic review and meta-Analysis. Ann Intern Med. 2012;157(12):865-877.
63. Staal JB, de Bie R, de Vet HC, Hildebrandt J, Nelemans P. Injection therapy for subacute and chronic low-back pain. Cochrane Database Syst Rev. 2008;(3):CD001824. doi:10.1002/14651858 .CD001824.pub3.
64. Buntin MB, Zaslavsky AM. Too much ado about two-part models and transformation? comparing methods of modeling Medicare expenditures. J Health Econ. 2004;23(3):525-542.
65. Dimick JB, Ryan AM. Methods for evaluating changes in health care policy: the difference-indifferences approach. JAMA. 2014;312(22):2401-2402.
66. Bertrand M, Duflo E, Mullainathan S. How much should we trust differences-in-differences estimates? Q J Econ. 2004;119(1):249-275.
67. Williams RL. A note on robust variance estimation for cluster-correlated data. Biometrics. 2000;56(2):645-646.
68. Chandra A, Cutler D, Song Z.Who ordered that? the economics of treatment choices in medical care. In: PaulyMV, McGuire TG, Barros PP, eds. Handbook of Health Economics. Vol. 2. Amsterdam, the Netherlands: Elsevier Science; 2012:397-432.
69. Smieliauskas F, Lam S, Howard DH. Impact of negative clinical trial results for vertebroplasty on vertebral augmentation procedure rates. J AmColl Surg. 2014;219(3):525-533.e1.
70. Howard DH, Shen Y-C. Comparative effectiveness research, technological abandonment, and health care spending. Adv Health Econ Health Serv Res. 2012;23:103-121.
71. Landon BE. Keeping score under a global payment system. N Engl JMed. 2012;366(5):393-395.
72. Cutler DM, Skinner JS, Stern AD, Wennberg DE. Physician Beliefs and Patient Preferences: A New Look at Regional Variation in Health Care Spending. Cambridge, MA: National Bureau of Economic ResearchWorking Paper Series; 2013;19320.
73. Gogineni K, Shuman KL, Chinn D, Gabler NB, Emanuel EJ. Patient demands and requests for cancer tests and treatments. JAMA Oncol. 2015;1(1): 33-39.
74. McWilliams JM, Dalton JB, Landrum MB, Frakt AB, Pizer SD, Keating NL. Geographic variation in cancer-related imaging: Veterans Affairs health care system versus Medicare. Ann Intern Med. 2014;161 (11):794-802.